Opening soon. Stay in the loop

goodmorrowJoin the opening list

KPV, explained.

Lysine-proline-valine. Research, safety questions, and treatment context.

Updated Clinical review pending · Educational draft

The form

Preparation matters

The routine

No personal schedule is set by this guide.

The evidence

See the evidence and source notes below.

Research, approval and availability are separate questions.

Legal status
Backed by FDA advisers, awaiting final rule

FDA advisers voted 8 to 6 on July 23, 2026 to allow compounding. The FDA's own review found no data on KPV given to people.

At Goodmorrow
Waitlist open

What it is

KPV is the last three amino acids of alpha-melanocyte stimulating hormone. In lab and animal studies it quiets inflammatory signaling, which is why it's pitched for colitis, eczema and gut repair.

What the evidence shows

Everything so far comes from cells and animals. When the FDA prepared its review for the July 2026 meeting, it searched the major databases and found no data on KPV given to people by any route. The committee recommended it anyway.

How Goodmorrow handles it

Given the evidence, KPV isn't something we'd lead with. If it becomes lawful and your clinician thinks it's reasonable for you, we'll prescribe it with clear expectations and a set end date.

Stacks that include it

Follow updates about KPV

Join the update list. This does not reserve a treatment or mean that future availability is assured.

What are you interested in?

We'll only use this to contact you about appointments, by phone, text or email. No health details needed here. See our privacy policy.

Questions people ask

Why is KPV in the KLOW stack?

It's added for its anti-inflammatory effect in lab studies. Nobody has tested KLOW, or KPV on its own, in a human trial.

Sources

  1. FDA documentJuly 23-24, 2026 Meeting of the Pharmacy Compounding Advisory Committee U.S. Food and Drug Administration, July 2026
  2. Secondary sourceFDA Panel Votes to Loosen Restrictions for Four Peptides PharmExec, July 2026
  3. Secondary sourceFDA advisory committee nominates six peptides for pharmacies to compound National Community Pharmacists Association, July 31, 2026

Good days ahead.

Join the opening list for appointment updates.

Join the opening list